chrisvoncsefalvay/vaers-outcomes huggingface dataset:
7 days after receiving vaccine I noticed itching at the injection site.  Upon further inspection I saw that my left deltoid had become red, hard, swollen, hot, itchy and painful. This is day two since onset of symptoms, my arm is still red, swollen, warm to touch, itchy and aching but is no longer hardened. I have taken nothing for the symptoms.
The pt experienced a fever, was lethargic, experienced vomiting and then recovered over a 4 day period beginning the day of the vax.
Right away, had tenderness at injection site, in face right jaw joint was tender and lasted for a couple of days. Monday 10/9, felt really fatigued, Tuesday 10/10, had severe headache, fever, not able to retain fluids, slept all day, coughing. 10/11 was vomiting, slept a lot, called doctor and was told to keep hydrated. 10/12, gradually starting eating, drinking tea, felt weak. 10/13, went to work, still felt sick, lips were ashen, pupils consricted/sensitivity to light. During the weekend, got more sleep. Today, 10/16, feels better but comments that was not able to do much for 1 week.
Lump in my neck on the left site. One is small from the first injection. The second lump is larger from the second injection and a tad sensitive and painful.
c/o frequent colds & flu sx since recvd flu shot; c/o sinus congestion et h/a frequently; tx consists of OTC meds; duration of sx until present, reoccurring sx;
SEVERE MENSTRUAL CRAMPING, NO DISCHARGE; DOUBLING OVER IN PAIN; FATIGUE (COULD GO LAY DOWN AND TAKE A NAP); This spontaneous report received from a patient concerned a 41 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: alcohol user, and non smoker, and other pre-existing medical conditions included: The patient had no known allergies. The patient did not have any history of drug abuse or illicit drug use. The patient had finished period last week (Saturday). The patient was taking vitamins in past. The patient was previously treated with sertraline for drug used for unknown indication. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 211A21A, expiry: UNKNOWN) dose was not reported, administered on 13-OCT-2021 for prophylactic vaccination. No concomitant medications were reported. On 14-OCT-2021, the patient experienced severe menstrual cramping, no discharge. On 14-OCT-2021, the patient experienced doubling over in pain. On 14-OCT-2021, the patient experienced fatigue (could go lay down and take a nap). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from severe menstrual cramping, no discharge, fatigue (could go lay down and take a nap), and doubling over in pain. This report was non-serious.
One day after injection I got the typical expected site pain, but the real reason I am submitting this is because today (3/24/2021) at the reported time (approx. 11L00 am) I noticed a hard, red, swollen area around the injection site. It is painful and quite warm to the touch, and slightly itchy at times.
Caller reports that his wife received her Moderna Primary Series vaccine and two Moderna booster doses and that his wife caught Covid-19 in December 2022; This spontaneous case was reported by a patient family member or friend and describes the occurrence of COVID-19 (Caller reports that his wife received her Moderna Primary Series vaccine and two Moderna booster doses and that his wife caught Covid-19 in December 2022) in an adult female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     Previously administered products included for COVID-19 prophylaxis: Spikevax, Moderna COVID-19 Vaccine and Spikevax. Past adverse reactions to the above products included No adverse event with Moderna COVID-19 Vaccine, Spikevax and Spikevax.    On an unknown date, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In December 2022, the patient experienced COVID-19 (Caller reports that his wife received her Moderna Primary Series vaccine and two Moderna booster doses and that his wife caught Covid-19 in December 2022). At the time of the report, COVID-19 (Caller reports that his wife received her Moderna Primary Series vaccine and two Moderna booster doses and that his wife caught Covid-19 in December 2022) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was provided. No treatment medications was provided.   Reporter did not allow further contact
Swelling at injection site beginning 24 hours after shot. Aprox. 3x3 inches, warm, red and itchy. Swelling of lips and tongue. Self administered 50mg of Benadryl and swelling went down. 48 hours later swelling came back, retook Benadryl. Continue to monitor swelling on left arm.
Patient reported having a headache the day after the vaccine but took tylenol. Then on 10/20, patient called the pharmacy and reported her arm was swollen, red, and warm to the touch from her shoulder down to her elbow
Information has been received from a medical assistant referring to a patient of unknown age and gender. The patient's concurrent conditions, concomitant medication and medical history were not provided. On 12-AUG-2016 the patient was inadvertently vaccinated with a dose of VARIVAX (lot#, expiration date, dose and route were unspecified) that was reconstituted with normal saline instead of the diluent supplied by Merck. No adverse effect was reported. Additional information has been requested.
SWELLING AND REDNESS TO THE INNER LEFT THIGH SEPERATE SITE FROM INJECTION
C/O dyspnea x 2 hours. 25 mg. BENADRYL, IM, 20 mg prednisone PO, albuterol 2 puffs, 500 cc N/S IV.
It was reported that a 68 year old female received Fluzone SV 98-99 USP, on 10/22/98.Reportedly after tha vaccination, the pt experienced scratchy throat, chills, HA, and watery eyes. 3 hours later the pt experienced orbital swelling, joint pain, muscle pain, and fatigue. From additional information received on 11/23/98 It was reported that the pt also c/o upper lip swelling. Reportedly the pt recovered from this experience. reviewed and no additional inofmarion available at this time.
Fever 103, sweats, chills, diarrhea, confusion. Loss of appetite.  Full body aches
patient has been admitted and discharged from hospital several times in last couple months.  He was admitted 5/18/22. the following information is admission  H/P and lab work. Chief complaint: Abnormal lab findings HPI: Patient is a 74-year-old male patient with no known medical history brought from medication list I can tell patient is having BPH, diabetes, gastroesophageal reflux disease, depression and some sort of neurological disorder for which he takes Keppra presented to emergency department today with a complaint of abnormal lab findings.  It appears that patient was sent from nursing home for a complaint of having a white count of 45.9.  Patient presented via EMS denies vomiting chest pain or fever.  Patient does report generalized weakness.  Patient is poor historian.  -Upon evaluation in the emergency room patient was found to have a white count of 48.1 hemoglobin 11 which is about his baseline absolute neutrophil count of 44.7 sodium of 134 BUN 37 creatinine 1.2 glucose 238 slightly elevated alkaline phosphatase at 147 normal lactate urinalysis showing large amount of leukoesterase small hemoglobin and bacteria.  Chest x-ray done in the emergency room shows patchy multifocal airspace opacities favored to represent pneumonia.  COVID-negative and lactate at 1.0.  Patient's vitals showing slight tachycardia on and off and tachypnea over 20.  Patient is being admitted for sepsis and evaluation is white count which is abnormally high despite the fact that he is having sepsis.
Loss of Taste; This spontaneous case was reported by a health care professional and describes the occurrence of AGEUSIA (Loss of Taste) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced AGEUSIA (Loss of Taste). At the time of the report, AGEUSIA (Loss of Taste) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.  No relevant concomitant medications were reported.
Numerous 1-3 mm vesicular erythematous lesions on both hands. Slightly painful. Itchy.
Pt. presented with respiratory failure and was tested positive for COVID. It was complicated by PNA. He was treated with Zithromax and Zosyn, supp O2, and steroids
Myalgia, Fever, chills, sweating Narrative:  Other Relevant History:
Patient received 1st dose of SHINGRIX on 8/22/2018. She experienced redness near the injection site and feeling sick for about 24 hours. Patient received 2nd dose of SHINGRIX on 11/2/2018. She felt sick again and experienced redness and swelling near the injection site for about 48 hours. Given BENADRYL cream to apply to area.
Itching, redness, swelling/hardness, pain and bruising at the injection site. Site is also bumpy like a localized rash and is warm to the touch.
This spontaneous report was received from a physician via a company representative and refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 10-JUL-2015, the patient was vaccinated with a dose of improperly stored VAQTA (10Pk 50U/1 mL) lot number K008984, expiration date of 21-OCT-2015 (route of administration was not reported), which was stored 3 times with the following lowest recorded temperatures: 34F (1.111 celsius degrees) for 88 hours, 32 F (0 celsius degrees) for 48 hours and 33 F (0.555 celsius degrees) for 40 hours. No highest reported temperatures were reported. The type of storage was refrigerator. No concomitant therapies were reported. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several cases from the same reporter. Additional information has been requested.
pt became weak & pale;did not completely pass out was able to walk to room w/help;very pale, hands cold;BP 120/90, P88, 3:30 P100 given soda to drink;BP 110/88, P88 3:40 BP 112/80, P96;3:55 BP 110/80, P96 d/ct w/mom instructed to eat;
Pt recvd 2nd dose of Hep B vax & exp nausea, vomiting, fever of 24 hrs duration; also exp conjunctivitis, malaise & h/a; pt ok next day; seen by MD only for ok to cont vax tx; MD r/o treatment;
Provider approached patient as she appear to have SOB and audible wheezing. Pt was sitting on a bench outside of clinic with her friend. Pt reports she just had her 4th dose of Moderna COVID vaccine. Pt states that she was monitored in the vaccine clinic for 30 minutes.  911 was called. Pt was asked if she has any inhaler with her. Staff found Albuterol inhaler in her purse and pt had two puffs of Albuterol inhaler administered by staff. Duoneb x1 verbal order per provider on site. VS: BP=154/97, HR=113, labor breathing noted. Pt was placed the pt on 6 liter of nasal cannula. Pt denies any chest pain and verbalized symptoms improving.  1336 VS: BP=138/112, HR=100, 100%/ 6 L N/C. RR=22 1339 EMS arrived and report given. Pt has hx of COPD and smoker. 1350 Pt was transported to ED per gurney with EMS and friend.   No reported reaction to previous moderna doses were noted in patient's chart.
No Second dose administered 47 days after the First dose; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (No Second dose administered 47 days after the First dose) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 035C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (No Second dose administered 47 days after the First dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (No Second dose administered 47 days after the First dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient was not sick after the first vaccine.   Concomitant medication not provided.  Treatment information not provided.
After Covid Vaccine (Pfizer) administration, immediately complained of tongue swelling.  METS team was called and employee was sent to Emergency Room.
Erythematous, swelling, and induration, about 10 cm x 5 cm. 10/3/06-Records received for DOX 08/25-8/27/06 DC Summary: DC DX resolving sensitivity reaction to immunization administration. Chief complaint: rule out cellulitis of left anterior thigh secondary to immunization administration. HX of present illness: 48 hours prior to admission received vaccination, presents with mass of swelling, regions of erythema and purplish discoloration occurring to this region that is on front of his left leg. No fever no chills but the site is bigger than any site he has ever had from any immunizations. No vomiting no diarrhea no other lesions.  Hospital Course: IV fluids, cool packs applied to left leg, Atrax syrup every 6 hours. Responded well to this treatment, by day of admission erythema was almost completely gone as well as swelling and warmth to the left anterior thigh.
Extreme vomiting, uncontrollable bowel movements (diarrhea), body aches, body shakes,  cold and hot at the same time, fatigue
vaccine administered 1/15/21, 10:45 am;  symptoms started at 9:45pm 1/18/21, and first symptoms were extreme dry mouth sinus pressure, severe headache, nasal discharge, feeling cold.  Symptoms worsened and peaked around 3pm 1/19/21 when I had a fever of 99.1 degrees F, some wheezing, dry cough, body aches and pains, sinus pain and congestion.
generalized urticaria w/in 24 hrs p/Hep B vax;
PNEUMOV AX 23 vaccine "every 5 years".; painful redness down the arm and into the chest; painful redness down the arm and into the chest; painful redness down the arm and into the chest; cant go to bed or sleep; This spontaneous report was received from a consumer refers to a 21-year-old female patient. The patient's concurrent conditions include allergy to animal, dust and mold. The patient's medical history included splenectomy in approximately June 1984 and deep vein thrombosis.   Concomitant therapies included fexofenadine hydrochloride, pseudoephedrine hydrochloride(ALLEGRA-D) and triamcinolone acetonide(NASACORT).    On 1984, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) dose 1 in the left arm for protection as she had no spleen, lot 3 and exp dat were not provided, the patient was vaccinated every 5 years.   The patient reported that "after a few hours, after getting the vaccine, she got pain down her arm to her elbow and also into her chest. The patient reported the "pain was so bad she could not go to bed and sleep." The patient reported this happened the first time she got the pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) in 1984 and every subsequent administration of the vaccine. The patient reported an unspecified physician gave the patient unspecified medication that alleviates the pain on unspecified dates. The patient reported that she recovered from the redness and pain on unspecified dates after each administration of the vaccine on unspecified dates. The patient was not hospitalized due to the events.  On an unspecified date the patient had a Streptococcus pneumoniae test was result was not provided. The relatedness of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) and the reporting events was not provided.
Headache; Sleepy; This is a spontaneous report from a contactable consumer (patient). A 61-years-old non-pregnant female patient received of first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in right arm on 20Feb2021 14:45 (Lot Number: El9269 and Expiration date: Unknown) as single dose for covid-19 immunization. Medical history included lupus. Concomitant medications included hydroxychloroquine sulfate (PLAQUENIL [HYDROXYCHLOROQUINE SULFATE]), levothyroxine sodium (SYNTHROID) and esomeprazole sodium (NEXIUM [ESOMEPRAZOLE SODIUM]) for an unspecified indication. On 20Feb2021 at 18:15, patient experienced Headache and sleepy. 3-4 hours after receiving the shot the patient became so sleepy she could not hold her eyes open and felt like she was melting. The patient also had a slight headache for about 2 days. She did take a nap for about 1.5 hours - woke up for a couple hours and then went to bed for the night. she felt ok in the morning except for the slight headache. The outcome of the events was recovered.  No follow-up attempts are possible. No further information is expected.
This case was reported by a health professional to a sales representative and described the occurrence of limb swelling in a child who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed (Infanrix).  The reporter stated that 4 children experienced the same event, however patient identifiers were not provided.  On an unspecified date in March 2004, the patient received the fifth dose of Infanrix (lot DTPA599C9).  At an unspecified time following the administration of Infanrix, the patient experienced swelling of the limb.  The outcome of the event is unknown.
According to patient, he started experiencing body aches around 6 pm and took ADVIL around 9 pm because of fever. Didn't sleep too well and woke up at 6 am coughing. Got up at 7 am to go bathroom and fainted hitting his head on floor tile requiring 8 stitches at hospital.
first dose 2 years ago, did not take second, sheltering during pandemic; This case was reported by a consumer via call center representative and described the occurrence of social problem in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose about 2 years ago of reporting date, at local pharmacy).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced social problem. On an unknown date, the outcome of the social problem was unknown.   Additional Information: GSK Receipt Date: 18-APR-2022 Reporter's Comments: The patient's husband reported the case. The patient received a first dose of the Shingrix vaccine but did not take a second dose because they were sheltering during the worst part of the Covid pandemic. The reporter asked should they start the two-dose vaccine series from the beginning again or should they go ahead and take the second dose now. Additional Supportive Information: This case has been linked to US2022AMR066360, reported for patient's wife.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR066360:Same reporter
At first, I seemed to have trouble handling a pill vial, I kept misplacing it.  Then, I was trying to do a certain number of clicks in an Ozempic pen and barely managed to do this.  It was as though I was having trouble counting.  I just felt flummoxed and had no idea what weird things were happening.  I tried to use my computer again and was completely incompetent as to the password.  I tried to read via a tablet or my phone and simply could not make sense of what I was reading. At this point I decided that it might be better to just try and get some rest in the hope that I would feel better in the morning.  Normally when I go to bed, I have two lamps, and both are governed by app.  Not only could I not recall the name, but I was also clueless about the commands that I would use to turn the lights off.  I manually turned off the lights. In the morning I felt a little better.  I could remember the term and could start recalling the commands.  I also could start recalling the password for my computer.  Normally in the morning I pray for about 20 minutes and over the decades the prayers are formulaic and somewhat comforting.  I had trouble concentrating on the exact nature of prayers that I was accustomed to for decades. Slowly, the day improved.  I read and used my computer.  Later in the day I could make out my prayers better.  That is kind of where it stands almost exactly 12 hours after this event.
MY KIDS GOT SICK FROM THESE ALL WINTER.; A spontaneous report has been received from a health professional. The report concerns a patient of unknown gender (age not provided) of Unknown ethnic origin.    No medical history was reported. The following demography was reported for the patient's parent:   Sex:    No concomitant products were reported.    The patient received Flumist (influenza virus vaccine live, intranasal) once/single administration, via nasal route, on an unknown date.     On an unknown date, the patient experienced my kids got sick from these all winter. (preferred term: Malaise).     Action taken of Flumist was not applicable.    The outcome of the event was unknown.    The event was considered non-serious.
Constant tinnitus and occasional head aches after the second dose. Tinnitus never stops and was never a problem before injections. Headaches were never a problem before the injections.
Extensive rash developed following fever. Fever started "a couple" days after initial vaccination and rash started after that. Rash was quite extensive and had the appearance of modified varicella. Patient was treated with supportive care and proper isolation was discussed. Patient recovered without incident.
Extremely sore vaccination site for days (arm). Followed by flu-like symptoms and then diagnosis of Type I (Juvenile) Diabetes.
Patient states experienced extreme pain in left arm (PREVNAR 13) with onset the same afternoon. States she had limited ROM and was unable to sleep overnight. Used TYLENOL for pain relief--is on blood thinners so only uses TYLENOL. States pain was to the point she considered going to the emergency room overnight but ended up not doing so. Requested her doctor not be contacted.. Net day states pain better but she still has compromised ROM.
Presented to ED who presents for evaluation of several complaints. Patient endorses having her first phase of vaccination early morning/afternoon yesterday. Becoming last night tachypneic and tachycardic per the husband to keep a close eye on her vital signs due to her extended complicated medical history. She began feeling short of breath yesterday evening which has persisted into the morning as well. She has been having about 12 hours of progressive now constant moderate/severe left-sided rib/left upper quadrant abdominal pain that radiates about this area and is stabbing in nature. Tachypnea because of most likely bilateral pleural effusion left more than right. Patient admitted. Bilateral pleural effusions left greater than the right.  Patient underwent thoracentesis and about 600 cc of turbid fluid was removed.  Fluid is neutrophilic exudate which is raised the possibility of acute inflammatory process.  No pneumonia seen on the CAT scan but only compressive atelectasis.  It is very concerning that patient's presentation is related to the Covid vaccination as an adverse effect. Initially she was placed on Maxipime and Flagyl but have been discontinued since.  She was empirically started on high-dose steroids for this inflammatory state and eventually switched to tapering dose of prednisone.  She will follow up with pulmonary in 2 weeks time with repeat chest x-ray.